Navigation Links
Overweight, insulin resistant women at greater risk of advanced breast cancer diagnosis, says study
Date:7/7/2008

Women who have risk factors commonly associated with Type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer, according to research to be presented today (Tuesday 8 July 2008).

University of Melbourne researcher Dr Anne Cust was a key collaborator on an international study which will today be presented to the Population Health 2008 Conference in Brisbane.

The study found that women who were overweight or had signs of insulin resistance such as elevated blood glucose or insulin levels were about 50 per cent more likely to be diagnosed with an advanced breast cancer tumor.

Researchers tracked more than 60,000 Swedish women over a 20-year-period from 1985 to 2005. All were cancer free when recruited and their blood tested for glucose, insulin and other hormones associated with obesity and diabetes risk.

Insulin resistance is most commonly caused by being overweight and inactive and is often a precursor to Type 2 diabetes.

Dr Cust said that previous research had shown a strong link between being overweight and increased breast cancer risk in post menopausal women but this study was the first to demonstrate the influence of insulin resistance on the stage of cancer diagnosis.

"Women with insulin resistance or who were overweight were less likely to be diagnosed with stage 1 breast cancers but at greater risk of being diagnosed with stage 2 to 4 tumors larger more advanced cancers,'' she said. "We know that being overweight and having insulin resistance is a risk factor for getting cancer but - in the case of breast cancer - our study indicates that the cancer will be more advanced."

Dr Cust said the research findings were particularly significant at a time when there were major public health concerns about obesity and Type 2 diabetes rates.


'/>"/>

Contact: Janine Sim-Jones
janinesj@unimelb.edu.au
040-089-3378
University of Melbourne
Source:Eurekalert

Page: 1

Related medicine news :

1. Overweight, Obese Women Improve Quality of Life With 10 to 30 Minutes of Exercise
2. Fat on chest and upper back increases risk of insulin resistance
3. Scientists explain how insulin secreting cells maintain their glucose sensitivity
4. Smart insulin nanostructures pass feasibility test, UT study reports
5. FDA Clears MDN-CGS(R) Intravenous Insulin Dosing Software
6. Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
7. Landmark trial to evaluate cardioprotective properties of insulin
8. Medtronic Mediterranean Launches Worlds First Arabic-Language Integrated Insulin Therapy for Improved Diabetes Management
9. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
10. Living donors may be best source of insulin-producing islets for diabetes treatment
11. Insulin regulates the secretion of the antiaging hormome Klotho
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 26, 2014 The report “TS-1 (Colorectal ... on the current treatment landscape, unmet needs, current pipeline ... is an anti-cancer drug which is typically used for ... also used for treating gastric cancer and pancreatic cancer. ... The drug was first approved in 1999 in Japan ...
(Date:12/25/2014)... 2014 The short film “Color of Honor” ... honor of a true 9/11 hero, Welles Remy Crowther. It ... the 24 hours of Nuremberg International Short Film Festival and ... Actress, screenwriter and director Luciana Lagana plays the ... with her husband, Gregory Graham - Graham plays ...
(Date:12/25/2014)... 2014 Recently, LunaDress.co.uk has updated its blog to ... accessories. Now, all of the models at LunaDress.co.uk come with big ... lifts the wedding veil can turn out to be a most ... wedding veil can always bring surprise to a wedding. On the ... to choose veils for a big day . , Going ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... on a "fountain of youth" drug that can delay the ... a new study suggests. Seniors received a significant boost ... a genetic signaling pathway linked to aging and immune function, ... The experimental medication, a version of the drug rapamycin, improved ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3
... , , ... Intelligence Associates, Inc. (BIA), an information management industry leader, ... of scalable, multi-language document repositories for electronic discovery and ... affordable cost shift in the legal document review market ...
... returning from a tryst with his Argentine mistress last June, ... "soul mate." His choice of words seemed to suggest that ... Chapur somehow made his sexual infidelity to his wife Jenny ... is that most women view emotional infidelity as worse, not ...
... ... ... Convention (USP) will convene a meeting of its member organizations on April 21–24 in ... pressing global and domestic public health issues. Known for its large and distinguished international ...
... brain function a serious concern, researchers say , TUESDAY, Jan. 26 ... infected with the virus that causes AIDS, new research suggests. , ... it -- or both -- are contributing to the aging. But ... about the same as in those of uninfected people who are ...
... ... daily workflow for safer, more effective patient care , ... San Mateo, Calif. (PRWEB) January 26, 2010 -- Epocrates, Inc., ... its enterprise use by health systems, hospitals and universities nationwide in 2009. The market demand ...
... double time to disease progression, study finds , ... cancer patients with the drug pazopanib (Votrient) slowed their ... found. , The phase 3 study included 233 patients ... cell carcinoma) that was locally advanced or had spread, ...
Cached Medicine News:Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 2Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 3Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 4Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 5Health News:BIA and Catalyst Release Per-Document Review & Hosting, a Cost-Effective Package 6Health News:His or hers jealousy? Study offers new explanation for sex differences in jealousy 2Health News:Public Health in Focus at International Conference 2Health News:Public Health in Focus at International Conference 3Health News:Premature Aging of the Brain Seen in HIV Patients 2Health News:Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information 2Health News:Health Systems, Hospitals and Universities Nationwide Chose Epocrates in 2009 for Trusted Point-of-Care Clinical Information 3Health News:New Drug Slows Advanced Kidney Cancer 2
(Date:12/24/2014)... Dec. 24, 2014  Novastem, a leader in ... patient in its study for ischemic stroke at ... Association, ischemic strokes account for 87 percent of ... patients in the study, entitled "Internal Research Protocol ... Mesenchymal Stem Cells and Intrathecal Administration of Neural ...
(Date:12/24/2014)... 24, 2014  Commonwealth Cornerstone Group (CCG) today announced the ... on Tuesday to help fund the expansion and consolidation of ... Sharon . PHN is the ... . It is the largest employer in ... people on staff. Currently, PHN Sharon offers scattered ...
(Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3
... FARMINGDALE, N.Y., Sept. 29 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, today announced plans to release fourth quarter and ... Thursday afternoon, October 1, 2009. Michael A. McManus, ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused ... of a Phase 2b trial for Empatic(TM) on Wednesday, September ... be followed by a live webcast and conference call at ... call and webcast to discuss the results of this clinical ...
Cached Medicine Technology:Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern 2
High temp cauteries, fine tip micro....
Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....
6 mm, 45 degree upwards, detachable....
Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
Medicine Products: